Alia Cibich
YOU?
Author Swipe
View article: Three decades of allogeneic transplantation showing improved survival, persistent relapse and post‑relapse outcomes of donor lymphocyte infusion versus second transplant
Three decades of allogeneic transplantation showing improved survival, persistent relapse and post‑relapse outcomes of donor lymphocyte infusion versus second transplant Open
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only potentially curative therapy for high-risk hematologic malignancies. Over the last three decades, transplant numbers have increased due to expanded age e…
View article: Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring <i>TP53</i> mutations
Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring <i>TP53</i> mutations Open
Allogeneic hematopoietic stem cell transplant (alloHCT) is considered for all patients with myeloid neoplasms (MNs) harboring TP53 mutations (TP53mut). The aim of this international study across 7 transplant centers in the United States an…
View article: Clonal Architecture of Donor-Derived Leukemia/Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplant
Clonal Architecture of Donor-Derived Leukemia/Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplant Open
BACKGROUND Donor derived leukemia (DDL) is a rare complication of allogeneic hematopoietic stem cell transplant (alloHSCT) with reported incidence ranging from 0.08% to 0.84% and median time to diagnosis 17 to 48 months post-alloHSCT (Aldo…
View article: Outcomes of ABO Incompatible Allogeneic Haematopoietic Stem Cell Transplant: A Single-Centre Retrospective Cohort Review
Outcomes of ABO Incompatible Allogeneic Haematopoietic Stem Cell Transplant: A Single-Centre Retrospective Cohort Review Open
Hematopoietic progenitor cell (HPC) transplantation has long been established as the optimal treatment for many hematologic malignancies. In the setting of allogenic HLA matched HPC transplantation, greater than 50% of unrelated donors and…
View article: Incidence of Decreased Bone Mineral Density Post Allogeneic Haemopoietic Stem Cell Transplant: Single Institution Retrospective Analysis
Incidence of Decreased Bone Mineral Density Post Allogeneic Haemopoietic Stem Cell Transplant: Single Institution Retrospective Analysis Open
Suite à une blessure de la main occasionnée par un objet rouillé, un homme se présente à l’officine avec deux ordonnances. La première comporte des immunoglobulines, la seconde émane du chirurgien qui a suturé le tendon lésé et prévoit l’a…